Interactions of tenofovir and tenofovir disoproxil fumarate with drug efflux transporters ABCB1, ABCG2, and ABCC2; role in transport across the placenta
Jazyk angličtina Země Anglie, Velká Británie Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
24413260
DOI
10.1097/qad.0000000000000112
PII: 00002030-201401020-00002
Knihovny.cz E-zdroje
- MeSH
- ABC transportér z rodiny G, člen 2 MeSH
- ABC transportéry metabolismus MeSH
- adenin analogy a deriváty metabolismus farmakokinetika MeSH
- buněčné linie MeSH
- krysa rodu Rattus MeSH
- látky proti HIV metabolismus farmakokinetika MeSH
- lidé MeSH
- nádorové proteiny metabolismus MeSH
- organofosfonáty metabolismus farmakokinetika MeSH
- P-glykoprotein metabolismus MeSH
- P-glykoproteiny MeSH
- potkani Wistar MeSH
- protein spojený s mnohočetnou rezistencí k lékům 2 MeSH
- proteiny spojené s mnohočetnou rezistencí k lékům metabolismus MeSH
- tenofovir MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- lidé MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- ABC transportér z rodiny G, člen 2 MeSH
- ABC transportéry MeSH
- ABCB1 protein, human MeSH Prohlížeč
- ABCC2 protein, human MeSH Prohlížeč
- ABCG2 protein, human MeSH Prohlížeč
- adenin MeSH
- látky proti HIV MeSH
- nádorové proteiny MeSH
- organofosfonáty MeSH
- P-glykoprotein MeSH
- P-glykoproteiny MeSH
- protein spojený s mnohočetnou rezistencí k lékům 2 MeSH
- proteiny spojené s mnohočetnou rezistencí k lékům MeSH
- tenofovir MeSH
OBJECTIVE AND DESIGN: Tenofovir (TFV) is used in pregnant women as a part of combination antiretroviral treatment to prevent mother-to-child transmission of HIV infection. We aimed to detect whether TFV and/or its prodrug, tenofovir disoproxil fumarate (TDF), are substrates of ATP-binding cassette (ABC) transporters that are functionally expressed in the placenta, namely P-glycoprotein (ABCB1/MDR1), Breast Cancer Resistance Protein (ABCG2/BCRP) and Multidrug Resistance-Associated Protein 2 (ABCC2/MRP2). We employed in-vitro cell-based assays and in-situ animal model to assess possible role of the efflux transporters in transplacental pharmacokinetics of TFV and TDF. METHODS: In-vitro transport assays were performed in MDCKII cells transduced with human ABCB1, ABCG2 or ABCC2. To quantify the effect of these transporters on TFV/TDF transplacental passage, we employed the in-situ model of dually perfused rat term placenta in open and closed setup. RESULTS: In-vitro assays revealed that TDF is a dual substrate of ABCB1 and ABCG2 but not of ABCC2. In contrast, TFV transport was not influenced by any of these transporters. Applying concentration-dependent studies and selective inhibitors, we further confirmed these findings in situ on the organ level; both ABCB1 and ABCG2 limited mother-to-fetus transfer of TDF whereas TFV transplacental passage was not affected by these ABC transporters. CONCLUSION: We propose limited mother-to-fetus transport of both TFV and TDF. While placental transport of TFV is restricted passively, by physical-chemical properties of the molecule, mother-to-fetus passage of TDF is actively hindered by placental ABCB1 and ABCG2 transporters, pumping this compound from trophoblast back to maternal circulation.
Citace poskytuje Crossref.org
Role of ABC and Solute Carrier Transporters in the Placental Transport of Lamivudine